Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

BusinesswireNov 22 05:05

CCORF Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $32

Futu NewsNov 21 20:31 · Ratings

ACADIA Pharmaceuticals: Strategic Leadership and Growth Prospects Support Buy Rating

TipRanksNov 21 19:55 · Ratings

Acadia Pharmaceuticals Announces Leadership Change Amid COO Departure

TipRanksNov 21 05:55

Express News | ACADIA Pharmaceuticals Inc - on Nov 18, Co Involuntarily Terminates COO Brendan Teehan

BreakingsNov 21 05:34

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireNov 16 05:05